Publications by authors named "Federico Colo"

Claim this Profile
U
Uncovering Surgical Dynamics and Trends in Early Breast Cancer Stage at Diagnosis: Key Insights From a Two-Decade Argentine Database Analysis.
Pablo Mandó, Verónica Fabiano, Soledad Gomez Guasch, Giuliana Colucci, Rodrigo Sánchez-Bayona

JCO Glob Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-Depth Analysis of the Peripheral Immune Profile of HER2+ Breast Cancer Patients on Neoadjuvant Treatment with Chemotherapy Plus Trastuzumab Plus Pertuzumab.
Ayelén Ivana Pesce Viglietti, María Belén Bordignon, Alexis Ostinelli, Manglio Miguel Rizzo, Gerardo Cueto

Int J Mol Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of modern parameters and their relationship with recurrence risk as assessed by Oncotype DX: real-world evidence.
Dana Narvaez, Jorge Nadal, Adrian Nervo, Victoria Costanzo, Claudio Paletta

Ecancermedicalscience· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin-Dependent Kinase 4/6 Inhibitor Outcomes in Patients With Advanced Breast Cancer Carrying Germline Pathogenic Variants in DNA Repair-Related Genes.
Luisina Bruno, Alexis Ostinelli, Federico Waisberg, Diego Enrico, Carolina Ponce

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin America.
Henry L Gomez, Juan E Bargallo-Rocha, Roberto J Billinghurst, Aníbal R Núñez De Pierro, Federico A Coló

JCO Glob Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database.
Verónica Fabiano, Pablo Mandó, Manglio Rizzo, Carolina Ponce, Federico Coló

JCO Glob Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Factors for Non-Sentinel Lymph Node Metastasis in Patients with ACOSOG Z0011 Criteria.
Carlos Martin Loza, Pablo Mandó, Carolina Ponce, Federico Coló, Veronica Fabiano

Breast Care (Basel)· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High neutrophil to lymphocyte ratio and decreased CD69NK cells represent a phenotype of high risk in early-stage breast cancer patients.
Pablo Mandó, Manglio Rizzo, María Paula Roberti, Estefanía Paula Juliá, María Betina Pampena

Onco Targets Ther· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Histologic Grade and High Ki-67 Expression Predict Phenotypic Alterations in Node Metastasis in Primary Breast Cancers.
Pablo Mandó, Manglio Rizzo, Constanza Perez de la Puente, Mercedes Maino, Carolina Ponce, Federico Colo

J Breast Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human breast adipose tissue: characterization of factors that change during tumor progression in human breast cancer.
Sabrina Johanna Fletcher, Paula Alejandra Sacca, Mercedes Pistone-Creydt, Federico Andrés Coló, María Florencia Serra

J Exp Clin Cancer Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade.
María P Roberti, Estefanía P Juliá, Yamila S Rocca, Mora Amat, Alicia I Bravo

Eur J Immunol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients.
María P Roberti, Yamila S Rocca, Mora Amat, María B Pampena, José Loza

Breast Cancer Res Treat· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis